DR info

Clinical trials : 3 / Drugs : 3 - (DrugBank : 2) / Drug target genes : 18 - Drug target pathways : 23

Drugs and their primary sponsors and trial info

Recombinant human somatotropin
   University of Milan
      1995   -   NCT00497484   Italy;
Theophylline
   Massachusetts General Hospital
      2019   Phase 4   NCT03718403   -
   Vanderbilt University Medical Center
      2020   Phase 2   NCT04551170   United States;
      2018   Phase 2   NCT03029429   United States;
      2015   Phase 2   NCT02463409   United States;
Theophylline ER
   Ashley Shoemaker
      2020   Phase 2   NCT04240821   United States;